ArticleArchives of dermatological research2025

Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients.

Rok Seon Choung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.